TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
NAUT

Nautilus Biotechnology, Inc.

Healthcare · Biotechnology

2.10$ -9.5% vs. previous close Closing price · As of: Nov 16, 2026

Statements

Balance Sheet

Nautilus Biotechnology, Inc. (NAUT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q3 26), "Total Assets" came in at 149 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NAUT
Line item Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26
306 289 273 260 243 228 213 201 191 178 164 149
177 185 171 144 133 142 151 134 106 99 88 90
19 26 25 4.4 28 33 34 24 12 15 13 10
173 181 167 141 130 139 148 131 103 96 84 87
40 39 37 36 34 33 32 32 34 33 32 32
9.1 9.2 8.7 8.7 7.6 8.2 8.1 9.0 8.0 8.3 8.6 9.8
3.5 3.7 3.8 4.0 4.1 4.2 4.2 4.2 3.8 3.9 4.0 4.1
1.6 1.9 1.6 1.5 1.0 0.8 1.0 0.9 0.9 1.2 1.1 1.3
265 249 235 223 209 194 181 169 157 144 131 117
-202 -221 -239 -255 -273 -290 -305 -318 -332 -347 -361 -377
125 125 125 125 126 126 126 126 126 127 127 127

Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?